Skip to main content

Table 1 Demographic and clinical characteristics of SLE patients

From: A cross-sectional study on the association of anxiety and depression with the disease activity of systemic lupus erythematosus

 

Depression(N = 200)

Non-depression(N = 125)

Total

χ2/ t

p value

Anxiety(N = 177)

Non-anxiety(N = 148)

Total

χ2/ t

p value

Age

44.57 ± 11.78

44.42 ± 12.12

44.51 ± 11.89

0.113

0.910

43.87 ± 11.92

45.28 ± 11.86

44.51 ± 11.89

-1.062

0.289

Gender

   

0.263

0.608

   

0.042

0.873

Male

13(0.07)

10(0.08)

23(0.07)

13(0.07)

10(0.07)

23(0.07)

Female

187(0.94)

115(0.92)

302(0.93)

164(0.93)

138(0.93)

138(0.42)

Educational levels

   

0.141

0.707

   

0.689

0.407

High school degree or less

121(0.61)

73(0.58)

194(0.60)

102(0.58)

92(0.62)

92(0.28)

Bachelor's degree or above

79(0.40)

52(0.42)

131(0.40)

75(0.42)

56(0.38)

56(0.17)

Annual household income

   

8.020

0.005

   

2.170

0.414

Less than 50,000

147(0.74)

73(0.58)

220(0.68)

126(0.71)

94(0.64)

94(0.29)

More than 50,000

53(0.27)

52(0.42)

105(0.32)

51(0.29)

54(0.36)

54(0.17)

Disease activity

   

22.790

0.000

   

32.996

0.000

Inactive-mild active

104(0.52)

98(0.78)

202(0.62)

85(0.48)

117(0.79)

202(0.62)

Moderate-severe active

96(0.48)

27(0.22)

123(0.38)

92(0.52)

31(0.21)

123(0.38)

SLEDAI 2000 score

13.61 ± 14.93

6.78 ± 5.16

10.98 ± 12.58

4.924

0.000

14.68 ± 15.63

6.56 ± 4.46

10.98 ± 12.58

6.110

0.000

Anti-dsDNA antibody

Positive

20 (0.10)

7 (0.06)

27 (0.08)

1.955

0.215

19 (0.11)

8 (0.05)

27 (0.08)

3.005

0.106

Negative

180 (0.9)

118 (0.94)

298 (0.92)

158 (0.89)

140 (0.95)

298 (0.92)

Time of onset

   

0.250

0.875

   

0.381

0.571

Within 5 years

99(0.50)

63(0.50)

162(0.50)

91(0.51)

71(0.48)

162(0.5)

More than 5 years

101(0.51)

62(0.50)

163(0.50)

86(0.49)

77(0.52)

77(0.24)

History of smoking

   

0.062

0.438

   

3.436

0.064

Yes

8(0.04)

3(0.02)

11(0.03)

9(0.05)

2(0.01)

2(0.01)

No

192(0.96)

122(0.98)

314(0.97)

168(0.95)

146(0.99)

146(0.45)

History of drinking

   

0.628

0.428

   

1.359

0.238

Yes

6(0.03)

2(0.02)

8(0.02)

6(0.03)

2(0.01)

2(0.01)

No

194(0.97)

123(0.98)

317(0.98)

171(0.97)

146(0.99)

146(0.45)

Clinical manifestation*

   

3.511

0.898

   

4.299

0.829

Skin and mucosaa

54(0.27)

29(0.23)

83(0.26)

0.584

0.445

46(0.26)

37(0.25)

83(0.26)

0.041

0.839

Musculoskeletalb

58(0.29)

18(0.14)

76(0.23)

9.152

0.002

50(0.28)

26(0.18)

76(0.23)

5.133

0.023

Hematologicalc

33(0.17)

18(0.14)

51(0.16)

0.256

0.613

34(0.19)

17(0.11)

51(0.16)

3.633

0.057

Lupus nephritisd

43(0.22)

17(0.14)

60(0.18)

3.189

0.074

39(0.22)

21(0.14)

60(0.18)

3.295

0.069

Neuropsychiatrice

87(0.44)

33(0.26)

120(0.37)

9.658

0.002

83(0.47)

37(0.25)

120(0.37)

16.587

0.000

  1. * Clinical manifestation included in this table was based on SLEDAI 2000 score
  2. aSkin and mucosa: rash, alopecia, mucosal ulcers
  3. bMusculoskeletal: arthritis and myositis
  4. cHematological: thrombocytopenia, leukopenia
  5. dLupus nephritis: Urinary casts, hematuria, proteinuria, and pyuria
  6. eNeuropsychiatric: seizure, psychosis, organic brain syndrome, visual disturbance, cranial nerve disorder, lupus headache, CVA